These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 15929805)

  • 21. Immunotherapy in gastrointestinal cancer: The current scenario and future perspectives.
    Abdul-Latif M; Townsend K; Dearman C; Shiu KK; Khan K
    Cancer Treat Rev; 2020 Aug; 88():102030. PubMed ID: 32505807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monoclonal antibodies in gastrointestinal cancers.
    Mitchell EP; Schlom J
    Semin Oncol; 1988 Apr; 15(2):170-80. PubMed ID: 2453081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cellular and biological therapies of gastrointestinal tumors: overview of clinical trials.
    Morse MA; Lyerly HK
    Ann Surg Oncol; 1999 Mar; 6(2):218-23. PubMed ID: 10082049
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunotherapy for gastrointestinal cancer: current status and strategies for improving efficacy.
    Elkord E; Hawkins RE; Stern PL
    Expert Opin Biol Ther; 2008 Apr; 8(4):385-95. PubMed ID: 18352844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Immunotherapy: Activation of a system not a pathway].
    Bernichon E; Rancoule C; Vallard A; Langrand-Escure J; Mery B; Guy JB; Magné N
    Bull Cancer; 2017 May; 104(5):462-475. PubMed ID: 28477871
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pancreatic cancer: role of the immune system in cancer progression and vaccine-based immunotherapy.
    Amedei A; Niccolai E; Prisco D
    Hum Vaccin Immunother; 2014; 10(11):3354-68. PubMed ID: 25483688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunotherapy for liver tumors: present status and future prospects.
    Matar P; Alaniz L; Rozados V; Aquino JB; Malvicini M; Atorrasagasti C; Gidekel M; Silva M; Scharovsky OG; Mazzolini G
    J Biomed Sci; 2009 Mar; 16(1):30. PubMed ID: 19272130
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical studies of human papilloma vaccines in cervical cancer.
    Adams M; Borysiewicz L; Fiander A; Man S; Jasani B; Navabi H; Evans AS; Mason M
    Adv Exp Med Biol; 2001; 495():419-27. PubMed ID: 11774604
    [No Abstract]   [Full Text] [Related]  

  • 29. Update on Mucin-1 immunotherapy in cancer: a clinical perspective.
    Rivalland G; Loveland B; Mitchell P
    Expert Opin Biol Ther; 2015; 15(12):1773-87. PubMed ID: 26453294
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dendritic cells in cancer immunotherapy.
    Vulink A; Radford KJ; Melief C; Hart DN
    Adv Cancer Res; 2008; 99():363-407. PubMed ID: 18037410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Efficacy of WT1 peptide-/MUC-1 peptide-pulsed dendritic cell therapy in 313 patients with a wide range of cancers].
    Kato Y
    Gan To Kagaku Ryoho; 2014 Oct; 41(10):1280-2. PubMed ID: 25335717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Personalized peptide vaccine for cancer treatment; now and its future].
    Waki K; Yamada A
    Nihon Rinsho; 2017 Feb; 75(2):251-256. PubMed ID: 30562860
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunotherapy of established (pre)malignant disease by synthetic long peptide vaccines.
    Melief CJ; van der Burg SH
    Nat Rev Cancer; 2008 May; 8(5):351-60. PubMed ID: 18418403
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Progress on the study of ovarian carcinoma vaccine ].
    Peng P; Shen J
    Zhonghua Fu Chan Ke Za Zhi; 2004 Jul; 39(7):500-2. PubMed ID: 15347482
    [No Abstract]   [Full Text] [Related]  

  • 35. Pemphigus: the promises of peptide immunotherapy.
    Di Bisceglie MB; Lucchese A; Crincoli V
    Immunopharmacol Immunotoxicol; 2009; 31(4):509-15. PubMed ID: 19874216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccines, Adjuvants, and Dendritic Cell Activators--Current Status and Future Challenges.
    Obeid J; Hu Y; Slingluff CL
    Semin Oncol; 2015 Aug; 42(4):549-61. PubMed ID: 26320060
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Towards a therapeutic breast cancer vaccine: the next steps.
    Emens LA
    Expert Rev Vaccines; 2005 Dec; 4(6):831-41. PubMed ID: 16372879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peptide-based vaccines for cancer therapy.
    Parmiani G; Russo V; Maccalli C; Parolini D; Rizzo N; Maio M
    Hum Vaccin Immunother; 2014; 10(11):3175-8. PubMed ID: 25483658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Application of autologous tumor cell vaccine and NDV vaccine in treatment of tumors of digestive tract.
    Liang W; Wang H; Sun TM; Yao WQ; Chen LL; Jin Y; Li CL; Meng FJ
    World J Gastroenterol; 2003 Mar; 9(3):495-8. PubMed ID: 12632504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intraperitoneal immunotherapy to prevent peritoneal carcinomatosis in patients with advanced gastrointestinal malignancies.
    Ströhlein MA; Heiss MM
    J Surg Oncol; 2009 Sep; 100(4):329-30. PubMed ID: 19697440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.